Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen s Assay-Development Collaboration with Utah Lab Kicks Off

NEW YORK, Feb. 26 - Nanogen has installed one of its NanoChip workstations at the Associated Regional and University Pathologists, a reference laboratory owned by the University of Utah.

The delivery was made in connection to Nanogen's development site program launched in December between the two groups to evaluate the NanoChip line to see if it can simplify gene-based assay development. Terms of their agreement call for Nanogen to give one of its NanoChip tools to ARUP in exchange for certain rights to assays developed by the reference lab.


Financial details of the agreement were not disclosed.

According to Nanogen, the partnership was set up to develop molecular diagnostic protocols that might be performed on the NanoChip cartridge and workstation.

According to Randy White, CEO of Nanogen, ARUP's "commitment to developing novel gene-based assays under ... [the agreement] may provide an important source of new content for our cartridges and may play a vital role in expanding our menu of customer applications."

Ronald L. Weiss, senior vice president of ARUP, said the collaboration supports his group's reckoning that molecular diagnostics "is an emerging, untapped market within esoteric testing."

Nanogen established its development site program to collaborate with selected customers in certain market segments, which the company said includes clinical research, the research divisions of reference diagnostic laboratories like ARUP, and genomics, pharmaceutical, biotechnology, and agrochemical companies.

Through the program, Nanogen said it hopes its customers might help develop assays for its platform in exchange for "preferential access" to its technology.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.